Literature DB >> 7845838

Nonpharmacological therapy of ventricular tachyarrhythmias: observations in 554 patients.

H J Trappe1, P Pfitzner, H G Figuth, P Wenzlaff, B Kielblock, H Klein.   

Abstract

It has been shown that conventional antiarrhythmic drug treatment is debatable, and there is growing interest in nonpharmacological techniques. We studied the outcome of 554 patients with ventricular tachycardia (VT) or ventricular fibrillation (VF) who underwent nonpharmacological techniques from March 1980 to June 1994 at our institution. Catheter ablation was performed in 51 patients (G1), map guided surgery in 147 (G2), and cardioverter defibrillator implantation (ICD) in 356 (G3). During a mean follow-up of 37 +/- 12 (< 1-137) months, incidence of sudden death (G1 4%, G2 6%, G3 3%) and cardiac death (G1 7%, G2 16%, G3 8%) were relatively low, and there was no significant differences between G1-G3. VT/VF recurrences occurred more frequently in G1 (57%) than in G2 (18%) (P < 0.01). ICD discharges occurred in 69% of patients. We conclude that nonpharmacological techniques lead to low sudden death rates; however, there is a high rate of recurrence in G1. Risk stratification is necessary to select the ideal therapy for each individual patient.

Entities:  

Mesh:

Year:  1994        PMID: 7845838     DOI: 10.1111/j.1540-8159.1994.tb03821.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  [Defibrillator therapy 1997. Prerequisites--results--prospects].

Authors:  H J Trappe
Journal:  Med Klin (Munich)       Date:  1997-07-15

2.  New perspective in arrhythmia and heart failure monitoring.

Authors:  H-J Trappe
Journal:  Clin Res Cardiol       Date:  2006       Impact factor: 5.460

3.  Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.

Authors:  H J Trappe; P Pfitzner; M Achtelik; H G Fieguth
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

4.  Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function.

Authors:  H J Trappe; P Wenzlaff; P Pfitzner; H G Fieguth
Journal:  Heart       Date:  1997-09       Impact factor: 5.994

5.  Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period.

Authors:  H J Trappe; P Wenzlaff; G Grellman
Journal:  J Interv Card Electrophysiol       Date:  1998-06       Impact factor: 1.900

6.  [Cerebral hemodynamics during implantation of cardioverter-defibrillator systems].

Authors:  T J Doering; H J Trappe; B Panning; H G Fieguth; B Steuernagel; B Schneider; S Piepenbrock; G C Fischer
Journal:  Med Klin (Munich)       Date:  1998-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.